Zai Lab Ltd (ZLAB) — 8-K Filings

8-K Filings (11)

• 8-K Filing — May 7, 2026
• Zai Lab Ltd. Enters Material Definitive Agreement — Oct 16, 2025 Risk: medium
  On October 13, 2025, Zai Lab Ltd. entered into a material definitive agreement, creating a direct financial obligation. The company, incorporated in the Cayman
• Zai Lab Ltd. Files 8-K for Security Holder Vote — Jun 18, 2025 Risk: low
  On June 18, 2025, Zai Lab Ltd. filed an 8-K report. The filing indicates that the company is submitting matters to a vote of its security holders. No specific d
• Zai Lab Ltd. Files 8-K on Financials — Feb 27, 2025 Risk: low
  Zai Lab Ltd. filed an 8-K on February 27, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exh
• Zai Lab Ltd. Files 8-K: Material Agreement and Financial Obligations — Jan 3, 2025 Risk: medium
  On January 2, 2025, Zai Lab Ltd. entered into a material definitive agreement. This filing also indicates the creation of a direct financial obligation or an ob
• Zai Lab Ltd. Files 8-K Report — Nov 15, 2024 Risk: medium
  On November 14, 2024, Zai Lab Ltd. entered into a material definitive agreement. The company, incorporated in the Cayman Islands with principal executive office
• Zai Lab Ltd. Files 8-K with Financial Statements — Nov 13, 2024 Risk: low
  On November 13, 2024, Zai Lab Ltd. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating a routine update rather than
• Zai Lab Ltd. Files 8-K for Material Definitive Agreement — Jul 9, 2024 Risk: medium
  On July 9, 2024, Zai Lab Ltd. entered into a material definitive agreement related to a direct financial obligation. The company, incorporated in the Cayman Isl
• Zai Lab Appoints New Chief Medical Officer — Jun 18, 2024 Risk: medium
  Zai Lab Ltd. announced on June 18, 2024, the appointment of Dr. William Lu as Chief Medical Officer and Executive Vice President, effective immediately. Dr. Lu
• Zai Lab Ltd. Announces Board Changes and Officer Appointments — Jun 11, 2024 Risk: medium
  On June 11, 2024, Zai Lab Ltd. filed an 8-K report detailing the departure of Director Yong (Ben) Kang and the appointment of Dr. Ge Li as the new Chairman of t
• Zai Lab Reports Undisclosed Material Agreement & Financial Obligation — Feb 8, 2024 Risk: high
  Zai Lab Ltd. filed an 8-K on February 8, 2024, reporting an "Entry into a Material Definitive Agreement" and the "Creation of a Direct Financial Obligation" on

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX